The impact of M-component type and immunoglobulin concentration on the risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance

Haematologica

Volumn 86, Issue 11, 2001, Pages 1172-1179

  Gregersen, H ^a   Mellemkjaer, L ^a   Ibsen, J S ^a   Dahlerup, J F ^a   Thomassen, L ^a   Sorensen H T ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Benign monoclonal gammopathies; Lymphoproliferative disorders; Multiple myeloma; Prognosis; Registries

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; CONCENTRATION RESPONSE; FEMALE; GENDER; HUMAN; HYPOGAMMAGLOBULINEMIA; IMMUNOGLOBULIN BLOOD LEVEL; INFANT; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MONOCLONAL IMMUNOGLOBULINEMIA; NEWBORN; REGRESSION ANALYSIS; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL TRANSFORMATION, NEOPLASTIC; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULIN ISOTYPES; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PARAPROTEINEMIAS; PARAPROTEINS; POISSON DISTRIBUTION; RISK FACTORS;

EID: 0035169680     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Frequency of pathological proteins (M-components) in 6,995 sera from an adult population
2. Monoclonal gammopathies in the adult population of Finistère, France
3. Monoclonal gammopathy of undetermined significance (MGUS)
4. Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance
5. "Benign" monoclonal gammopathy: After 20 to 35 years of follow-up
6. The physiopathological significance of benign monoclonal gammopathy: A study of 64 cases
7. The natural history of monoclonal gammopathy of undetermined significance. A 5- to 20-year follow-up of 263 cases
8. Malignant transformation of monoclonal gammopathy of undetermined significance among out-patients of a community hospital in southeastern Netherlands
9. Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy
10. Risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance
11. Agarose gel electrophoresis
12. The Danish Cancer Registry: History, content, quality and use
13. Non-parametric estimation from incomplete observations
14. Long-term study of gammopathies. Clinically benign cases showing transition to malignant plasmacytomas after long periods of observation
15. The spectrum of IgM monoclonal gammopathy in 430 cases
16. Multivariant cohort analysis
17. Prognosis in monoclonal gammopathy of undetermined significance
18. Monoclonal gammopathies of undetermined significance. Clinical course and biological aspects of 397 cases
19. Prognostic features of asymptomatic multiple myeloma
20. Classification and prognostic evaluation in multiple myeloma. A retrospective study of relationship of survivals and responses to chemotherapy to immunological types, 20 single prognostic factors, 15 clinical staging systems, and 6 morphological classifications
21. Monitoring of monoclonal gammopathies: Rational use of densitometry and rate nephelometry
22. Diagnostic value of the concentration of M-component in initial classification of monoclonal gammopathy
23. Monoclonal gammopathies of undetermined significance